LDDD (Longduoduo Co) 3-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LDDD Longduoduo Co Ltd LDDD
47 GF Score
Price $0.51
GF Value $2.30
! 1 Warning Sign
View Full Analysis

What is Longduoduo Co 3-Year EBITDA Growth Rate?

Longduoduo Co LDDD -14.04% 47 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates LDDD with a GF Score™ of 47/100 and a GF Value™ of $2.30. The stock has 1 warning sign investors should review.

Longduoduo Co's EBITDA per Share for the three months ended in Mar. 2026 was $-0.01.

During the past 12 months, Longduoduo Co's average EBITDA Per Share Growth Rate was -131.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Longduoduo Co  (OTCPK:LDDD) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Longduoduo Co 3-Year EBITDA Growth Rate Related Terms

LDDD vs AWHL, BIAF, MBAI: 3-Year EBITDA Growth Rate Comparison

For the Diagnostics & Research subindustry, Longduoduo Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longduoduo Co 3-Year EBITDA Growth Rate vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Longduoduo Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Longduoduo Co's 3-Year EBITDA Growth Rate falls into.


LDDD
47GF Score
Longduoduo Co Ltd LDDD
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Longduoduo Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Longduoduo Co (LDDD) has a 3-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Longduoduo Co and its competitors.
Is Longduoduo Co's 3-Year EBITDA Growth Rate too high?
Longduoduo Co's current 3-Year EBITDA Growth Rate is 0.00%. Overall, Longduoduo Co has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Longduoduo Co's 3-Year EBITDA Growth Rate compare to AWHL and BIAF?
Longduoduo Co's 3-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. The industry median 3-Year EBITDA Growth Rate is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Diagnostics & Research company?
The median 3-Year EBITDA Growth Rate among Medical Diagnostics & Research companies is 11.00, based on 165 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Longduoduo Co and its competitors. For the Medical Diagnostics & Research industry, the median 3-Year EBITDA Growth Rate is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longduoduo Co's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longduoduo Co stock overvalued right now?
Longduoduo Co (LDDD) has a current 3-Year EBITDA Growth Rate of 0.00%. The stock's GF Value™ is $2.30, compared to a current price of $0.51 — trading 77.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Longduoduo Co's overall GF Score™ is 47/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Longduoduo Co (LDDD), the current 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Longduoduo Co (LDDD) Overvalued in 2026?

Based on GuruFocus' analysis, Longduoduo Co stock appears to be undervalued. The current stock price of $0.51 is trading 77.8% below its estimated GF Value™ of $2.30.

Key valuation signals for LDDD:

  • 3-Year EBITDA Growth Rate: 0.00%
  • GF Value™: $2.30 vs. price of $0.51 (77.8% below fair value)
  • GF Score™: 47/100 with 1 warning sign

No single metric tells the full story. See the LDDD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Longduoduo Co Business Description

Address G3-5-8016, Ruyi Headquarters Base, Hohhot Economic Development Zone, Inner Mongolia, Shui’an, CHN, 010000
Longduoduo Co Ltd through its operating subsidiaries, is engaged in providing preventive healthcare solutions. It offers a wide range of comprehensive preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other related services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. Its revenues are mainly generated from customers in the People's Republic of China.
47GF Score

Get the complete analysis for LDDD

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$2.30
GF Value